2020
DOI: 10.1080/14779072.2020.1732210
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological management of atrial fibrillation in patients with heart failure with reduced ejection fraction: review of current knowledge and future directions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 146 publications
0
2
0
Order By: Relevance
“…In our case patient's LVEF is 20%. [14] Digoxin serum levels should range between 0.8 and 2 ng/mL. It is critical to draw blood at least 6 to 8 hours after the last dose when measuring digoxin serum levels.…”
Section: Discussionmentioning
confidence: 99%
“…In our case patient's LVEF is 20%. [14] Digoxin serum levels should range between 0.8 and 2 ng/mL. It is critical to draw blood at least 6 to 8 hours after the last dose when measuring digoxin serum levels.…”
Section: Discussionmentioning
confidence: 99%
“…Cardiac glycosides, such as digitalis and digoxin, have been used in clinical practice for a long time. This medicine was approved by the FDA in 1954 and is used to treat a variety of cardiac conditions including atrial flutter, atrial fibrillation, and heart failure with accompanying symptoms (Grubb & Mentz 2020).…”
Section: Introductionmentioning
confidence: 99%